June 23-25, 2022 |
Booth #30
Meet with the ProSciento team of experts at EASL’s International Liver Congress™ and learn about how our unparalleled NASH trial experience, proven, science-driven strategies, and specialized services benefit you, while also advancing research in biomarker discovery and disease progression.
Benefits of working with ProSciento:
- More than 12 years of experience designing and conducting NASH clinical trials
- Leading provider: more early phase NAFLD and NASH clinical trials conducted than any other U.S.-based provider
- More than 4,500 prescreened patients at-risk for NAFLD and NASH ready for your clinical trials
Meet With ProSciento’s Scientific and Business Development Teams
Marcus Hompesch, M.D.
Chief Executive Officer and Chairman of the Board
Heidi Guthrie
Senior Director of Clinical Strategies and Logistics
Michelle Mazuranic Ph.D., M.S.M., R.D.
Vice President, Medical and Regulatory Affairs
Casey Ustick
Senior Director, Global Business Development
